Form 8-K - Current report:
SEC Accession No. 0001520138-21-000221
Filing Date
2021-04-27
Accepted
2021-04-27 17:19:14
Documents
38
Period of Report
2021-04-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bivi-20210427_8k.htm   iXBRL 8-K 51232
2 EXHIBIT 2.1 bivi-20210427_8kex2z1.htm EX-2.1 465358
3 EXHIBIT 99.1 bivi-20210427_8kex99z1.htm EX-99.1 25039
4 EXHIBIT 99.2 bivi-20210427_8kex99z2.htm EX-99.2 11513
9 GRAPHIC bv001_v1.jpg GRAPHIC 51312
10 GRAPHIC bv002_v1.jpg GRAPHIC 95861
11 GRAPHIC bv003_v1.jpg GRAPHIC 59385
12 GRAPHIC bv004_v1.jpg GRAPHIC 41220
13 GRAPHIC bv005_v1.jpg GRAPHIC 48738
14 GRAPHIC bv006_v1.jpg GRAPHIC 45087
15 GRAPHIC bv007_v1.jpg GRAPHIC 51591
16 GRAPHIC bv008_v1.jpg GRAPHIC 68149
17 GRAPHIC bv009_v1.jpg GRAPHIC 49398
18 GRAPHIC bv010_v1.jpg GRAPHIC 71814
19 GRAPHIC bv011_v1.jpg GRAPHIC 47767
20 GRAPHIC bv012_v1.jpg GRAPHIC 63518
21 GRAPHIC bv013_v1.jpg GRAPHIC 53379
22 GRAPHIC bv014_v1.jpg GRAPHIC 63649
23 GRAPHIC bv015_v1.jpg GRAPHIC 88465
24 GRAPHIC bv016_v1.jpg GRAPHIC 52670
25 GRAPHIC bv017_v1.jpg GRAPHIC 45876
26 GRAPHIC bv018_v1.jpg GRAPHIC 67548
27 GRAPHIC bv019_v1.jpg GRAPHIC 33419
28 GRAPHIC bv020_v1.jpg GRAPHIC 47042
29 GRAPHIC bv021_v1.jpg GRAPHIC 34397
30 GRAPHIC bv022_v1.jpg GRAPHIC 41934
  Complete submission text file 0001520138-21-000221.txt   2564355

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE bivi-20210427.xsd EX-101.SCH 3542
6 XBRL DEFINITION FILE bivi-20210427_def.xml EX-101.DEF 27303
7 XBRL LABEL FILE bivi-20210427_lab.xml EX-101.LAB 36105
8 XBRL PRESENTATION FILE bivi-20210427_pre.xml EX-101.PRE 25925
31 EXTRACTED XBRL INSTANCE DOCUMENT bivi-20210427_8k_htm.xml XML 4374
Mailing Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404
Business Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404 310-444-4300
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39015 | Film No.: 21860106
SIC: 2834 Pharmaceutical Preparations